Acme United Corporation Recalls Med-Nap BZK Antiseptic Towelettes Due to CGMP Deviations
Acme United Corporation has voluntarily recalled specific lots of Med-Nap BZK Antiseptic Towelettes nationwide due to deviations from Current Good Manufacturing Practice (CGMP) standards.
What Happened
Acme United Corporation has initiated a voluntary recall of Med-Nap BZK Antiseptic Towelettes. The recall was prompted by deviations from Current Good Manufacturing Practice (CGMP) requirements. The U.S. Food and Drug Administration (FDA) has classified this as a Class II recall, which was officially reported on March 11, 2026.
Which Products Are Affected
The recall affects Med-Nap BZK Antiseptic Towelettes (Benzalkonium Chloride 0.13%), sized 5” x 7”, sold in bulk quantities of 1,000 units per package.
- Brand Name: Med-Nap
- NDC Number: 0924-0246-02
- UPC: 0092265940061
- Recall Number: D-0367-2026
- Affected Lot Numbers and Expiration Dates:
- Lot # MN23323 (Exp. Date Jul 2028)
- Lot # MN31323 (Exp. Date Oct 2028)
- Lot # MN21622 (Exp. Date Jul 2027)
- Lot # MN13123 (Exp. Date Apr 2028)
These products were distributed nationwide throughout the United States.
What You Should Do
Consumers, retailers, and healthcare facilities should immediately check their stock for the affected lot numbers listed above. If you possess any of the recalled products, you should stop using them and contact Acme United Corporation for instructions regarding the return or disposal of the items. The firm initiated the notification process via letter to its distributors and customers.
Why This Matters
Adherence to Current Good Manufacturing Practice (CGMP) is essential to ensure the safety, identity, strength, and quality of drug products. Deviations from these standards mean the manufacturing process may not have been sufficiently controlled, potentially compromising the product’s integrity.
Source
Information provided by the FDA Enforcement Report.
Source: FDA Official Notice